Agilon Health SG&A Expenses 2020-2025 | AGL
Agilon Health sg&a expenses from 2020 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Agilon Health Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $269 |
| 2023 | $286 |
| 2022 | $208 |
| 2021 | $428 |
| 2020 | $137 |
| 2019 | $123 |
| Agilon Health Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $66 |
| 2024-12-31 | $60 |
| 2024-09-30 | $63 |
| 2024-06-30 | $70 |
| 2024-03-31 | $76 |
| 2023-12-31 | $65 |
| 2023-09-30 | $72 |
| 2023-06-30 | $79 |
| 2023-03-31 | $70 |
| 2022-12-31 | $64 |
| 2022-09-30 | $52 |
| 2022-06-30 | $52 |
| 2022-03-31 | $40 |
| 2021-12-31 | $26 |
| 2021-09-30 | $47 |
| 2021-06-30 | $318 |
| 2021-03-31 | $38 |
| 2020-12-31 | $41 |
| 2020-09-30 | $32 |
| 2020-06-30 | $36 |
| 2020-03-31 | $28 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.869B | $6.061B |
| agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.516B | 25.79 |
| Elevance Health (ELV) | United States | $86.906B | 11.21 |
| CVS Health (CVS) | United States | $79.797B | 9.92 |
| Cencora (COR) | United States | $55.901B | 19.45 |
| DiDi Global (DIDIY) | China | $23.062B | 35.00 |
| Natera (NTRA) | United States | $22.600B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| Solventum (SOLV) | United States | $13.040B | 13.80 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.997B | 0.00 |
| CochLear (CHEOY) | Australia | $11.519B | 0.00 |
| ICON (ICLR) | Ireland | $10.888B | 10.12 |
| Doximity (DOCS) | United States | $10.770B | 49.86 |
| Revvity (RVTY) | United States | $10.667B | 18.36 |
| Viatris (VTRS) | United States | $9.929B | 3.41 |
| HealthEquity (HQY) | United States | $9.746B | 42.69 |
| Avantor (AVTR) | United States | $8.825B | 12.82 |
| Medpace Holdings (MEDP) | United States | $8.438B | 22.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.340B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.935B | 13.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.103B | 24.19 |
| BrightSpring Health Services (BTSG) | United States | $4.095B | 37.90 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Alignment Healthcare (ALHC) | United States | $2.926B | 0.00 |
| Concentras Parent (CON) | United States | $2.786B | 16.10 |
| Organon (OGN) | United States | $2.389B | 2.54 |
| Ardent Health Partners (ARDT) | United States | $2.110B | 8.99 |
| GeneDx Holdings (WGS) | United States | $1.974B | 76.01 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| Progyny (PGNY) | United States | $1.831B | 40.30 |
| PACS (PACS) | United States | $1.579B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.507B | 30.14 |
| Teladoc Health (TDOC) | United States | $1.216B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.196B | 9.10 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| CareDx (CDNA) | United States | $1.045B | 16.31 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 7.20 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.686B | 10.38 |
| Embecta (EMBC) | United States | $0.583B | 3.93 |
| LifeMD (LFMD) | United States | $0.549B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 44.83 |
| InnovAge Holding (INNV) | United States | $0.536B | 0.00 |
| SBC Medicals (SBC) | United States | $0.529B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.93 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| Oncology Institute (TOI) | United States | $0.249B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.235B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| KindlyMD (NAKA) | United States | $0.097B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |